Spots Global Cancer Trial Database for myeloid sarcoma
Every month we try and update this database with for myeloid sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes | NCT05057299 | Acute Myeloid L... | retrospective d... | 18 Years - | King Hussein Cancer Center | |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers | NCT03589729 | Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch... | Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin | 12 Years - | M.D. Anderson Cancer Center | |
| Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement | NCT06111612 | Acute Myeloid L... Myelodysplastic... Chronic Myelomo... Myeloid Sarcoma Extramedullary ... | 18 Years - 55 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | ||
| PET-CT in AML for Detection of Extramedullary AML Manifestations | NCT01278069 | Newly Diagnosed... | 18 Years - 80 Years | Technische Universität Dresden | ||
| Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT01371981 | Acute Myeloid L... Leukemia Cutis Myeloid Neoplas... Myeloid Sarcoma | Asparaginase Bortezomib Cytarabine Daunorubicin Hy... Etoposide Laboratory Biom... Mitoxantrone Hy... Pharmacological... Quality-of-Life... Questionnaire A... Sorafenib Tosyl... | - 29 Years | National Cancer Institute (NCI) | |
| Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation | NCT02259348 | Acute Lymphobla... Acute Myeloid L... Myeloid Sarcoma Chronic Myeloge... Juvenile Myelom... Myelodysplastic... Non-Hodgkin Lym... | Cyclophosphamid... Fludarabine G-CSF Interleukin-2 Melphalan Thiotepa Rituximab Natural killer ... T-cell depleted... CD45RA-depleted... | - 21 Years | St. Jude Children's Research Hospital | |
| Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation | NCT02790515 | Acute Lymphobla... Acute Myeloid L... Myeloid Sarcoma Chronic Myeloid... Juvenile Myelom... Myelodysplastic... Non-Hodgkin Lym... | Anti-thymocyte ... Blinatumomab Cyclophosphamid... Fludarabine G-CSF Melphalan Mesna Rituximab Tacrolimus Thiotepa HPC,A Infusion CliniMACS Sirolimus | - 21 Years | St. Jude Children's Research Hospital | |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers | NCT03589729 | Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch... | Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin | 12 Years - | M.D. Anderson Cancer Center | |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers | NCT03589729 | Acute Myeloid L... Blast Phase Chr... Blasts 10 Perce... High Risk Myelo... Myeloid Sarcoma Myeloproliferat... Philadelphia Ch... | Cladribine Cytarabine Dexrazoxane Hyd... Gemtuzumab Ozog... Idarubicin | 12 Years - | M.D. Anderson Cancer Center | |
| Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia | NCT02658487 | Acute Myeloid L... Acute Myeloid L... Acute Myeloid L... Myeloid Sarcoma Secondary Acute... Therapy-Related... Therapy-Related... | Cytarabine Vosaroxin | 18 Years - | Vanderbilt-Ingram Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
